Unilife Corporation (UNS)

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!

General Information
Company Name: Unilife Corporation
Stock Code: UNS
Website: www.unilife.com.au
GICS Sub-Industry: Health Care Equipment
Market Cap ($M): 168
Equiv. Shares (M): 275

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.610 $ 0.620 $ 0.620 $ 0.610 $ 0.610 78,947 0%

Company Overview

Business Description:
Unilife Corporation Limited (UNS) is a designer, manufacturer and supplier of innovative injectable drug delivery systems that can enhance and differentiate the injectable drugs, biologics and vaccines, or collectively injectable therapies, of pharmaceutical and biotechnology customers. UNS has a portfolio of proprietary product platforms including pre-filled syringes, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and other novel injectable drug delivery systems.

Strategy Analysis:
UNS is focussed on the development, production and sale of safety syringes, the expansion of their global operational and commercial presence and, the establishment of long term supply relationships with multinational pharmaceutical and healthcare equipment companies. Unilife Corporation reported a net loss of US$27.14m for the half-year ended 31 December 2012. Revenues from ordinary activities were US$1.4m, down 54.3% from the same period last year. Basic and Diluted EPS were (0.35) US cents compared to (0.35) US cents last year. The net operating cash outflow was US$20.74m compared to an outflow of US$18.76m in the pcp. No dividend was declared.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014  A -61.5 -10.5 -- 0.0 0.0 0.0 --
2013  A -68.1 -14.0 -- 0.0 0.0 0.0 --
2012  A -51.3 -12.7 -- 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Cochlear (COH) $4,013 M -0.2934 0.5815 0.1669 42.8197 27.0756 23.2039 3.61 2.69 3.15
Greencross (GXL) $944 M 2.8120 0.1526 0.2545 26.2636 22.7872 18.1643 1.48 2.16 2.72
ResMed (RMD) $8,707 M 0.1393 0.0770 0.1222 24.1099 22.3859 19.9488 1.75 2.06 2.05
Unilife (UNS) $168 M -- -- -- -- -- -- 0.00 -- --

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
UNS -- -- 58.1 -- 23.0
Market 0.91 15.2 1.18 1.87 1.52
Sector 0.66 18.6 2.35 1.65 1.98

Name Position Start Date
Mr Alan Denis Shortall Chief Executive Officer 02 July 2009
Mr Slavko (Jim) James Joseph Bosnjak Non-Executive Chairman 05 November 2009
Mr Jeffrey Noel Carter Non-Executive Director 05 November 2009
Mr William Galle Non-Executive Director 05 November 2009
Mr John M Lund Non-Executive Director 05 November 2009
Ms Mary Katherine (Kate) Wold Non-Executive Director 11 May 2010

Name Position
R. Richard Wieland II Chief Financial Officer and Executive Vice President
Ramin Mojdeh Chief Operating Officer and Executive Vice President
John Ryan Company Secretary,Senior Vice President and General Counsel
Mark V. Iampietro Vice President of Quality and Regulatory Affairs
J. Christopher Naftzger Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer

Substantial Shareholders
Holding Name
-- (--%) Not Disclosed in Annual Report

Calendar of Events
Date Event
15 September 2015 Report (Annual)
28 August 2015 Report (Prelim)
10 February 2015 Report (Interim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.


Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Investing in Art

An educational booklet with useful, practical tips to help you make better-informed decisions about investing in art.

More details...


Australian Share Market - Close Up

CMC Markets 11/11/2014 | The Australian share market is in a decision zone - and trading from here may set the direction for the rest of the year.

Prices slashed - everything must go!

Nick Swales, Regional Director, Newcastle Office, Rathbones 27/10/2014 | “If you want to have a better performance than the crowd, you must do things differently from the crowd.” Sir John Templeton.

Aussie share market bulls now have company

Ric Spooner (Chief Market Analyst, CMC Markets) 20/10/2014 | Today, Australian investors will not have to go it alone buying stocks as they did for much of last week. Bargain hunters this morning will be supported by the morale boosting encouragement of a 3% turnaround in the German Dax and a 264 point rally in the Dow Jones.

The Importance of Ignoring the Noise of the Market

Carl Richards, director of investor education at the BAM Alliance 17/10/2014 | “As odd as it may sound, the sooner you start treating your investments like you treat life, the happier you’ll be with the outcome.”

You only dance twice

William H. Gross, Janus Capital Group 16/10/2014 | “Financial markets are artificially priced. In the bond market, there is nothing normal about a three year German Bund yielding “minus” 10 basis points.”

The Big Picture - Australia 200 Index

CMC Markets 8/10/2014 | Share market indices around the globe are breaking down. While analysts cast around for reasons, it’s clear that a time factor is in play. Simply put, many investors “feel” a correction is overdue. How low could it go?


Sponsored Links